Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    16283615 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)
Condition: Multiple Sclerosis (MS)
Interventions: Drug: Tecfidera;   Drug: Placebo
2 Recruiting Short and Long Term Multiple Outcomes in Persons With Multiple Sclerosis Treated by Fampridine.
Condition: Multiple Sclerosis
Intervention: Drug: Fampridine
3 Recruiting Spinal Direct Current Stimulation Effects on Pain in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Other: Experimental treatment;   Other: Placebo treatment
4 Completed Ampyra for Optic Neuritis in MS
Conditions: Multiple Sclerosis;   Optic Neuritis
Interventions: Drug: Dalfampridine/Placebo;   Drug: Placebo/Dalfampridine
5 Recruiting Prevalence of Fabry Disease in a Defined Population at Risk - Patients Formerly Diagnosed With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:

Study has passed its completion date and status has not been verified in more than two years.